Survival and bioturbation of the amphipod Monoporeia affinis in sulphide-rich sediments

Autor: H. Modig, Emil Ólafsson

Publikováno v: Marine Biology. 138:87-92

Laboratory experiments were conducted to investigate the survival rate of Monoporeia affinis in sulphide-rich sediment with oxic overlying water, and the effect of amphipod bioturbation on sulphide and oxygen profiles. As long as the oxygen content i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9aa630553bd9b067f1bf9bd087be4fbf
https://doi.org/10.1007/s002270000445

Species specific uptake of radio-labelled phytodetritus by benthic meiofauna from the Baltic Sea

Autor: H. Modig, E. Ólafsson, W.J. Van de Bund

Publikováno v: Marine Ecology Progress Series, 177, 63-72. Inter-Research

The diatom Sheletonema costatum is one of the dominant phytoplankton species during spring in the northern Baltic Sea. We followed the uptake of radio-labelled S, costatum by all major meiofauna species in a laboratory experiment. The uptake of label

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d946b0dd15bbf8b9d244eb5fb5fb43d
https://doi.org/10.3354/meps177063

Effects of the coexisting Baltic amphipods Monoporeia affinis and Pontoporeia femorata on the fate of a simulated spring bloom diatom

Autor: Emil Ólafsson, W.J. Van de Bund, R. Elmgren, H. Modig

Publikováno v: Marine Ecology Progress Series, 212, 107-115. Inter-Research

A laboratory experiment was performed to quantify the fate of diatom phytodetritus and how this is affected by the presence of benthic amphipods. A Baltic Sea spring bloom sedimentation event was simulated by adding C-14-labeled diatoms (Skeletonema

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81ba5b97b6adda9c59fdd5868cf7491b
https://pure.knaw.nl/portal/en/publications/e5e5b4b8-b921-4349-8d74-b8abae5b9aeb

Early mortality in children with cancer in Denmark and Sweden: The role of social background in a setting with universal healthcare.

Autor: Mogensen H; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Erdmann F; Childhood Cancer Research Group, Danish Cancer Institute, Copenhagen, Denmark.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Mader L; Childhood Cancer Research Group, Danish Cancer Institute, Copenhagen, Denmark.; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.; Cancer Registry Bern-Solothurn, University of Bern, Bern, Switzerland., Vrelits Sørensen G; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark., Talbäck M; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Tjørnelund Nielsen T; Childhood Cancer Research Group, Danish Cancer Institute, Copenhagen, Denmark., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Heyman M; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Winther JF; Childhood Cancer Research Group, Danish Cancer Institute, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Feychting M; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Tettamanti G; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Kenborg L; Childhood Cancer Research Group, Danish Cancer Institute, Copenhagen, Denmark.

Publikováno v: International journal of cancer [Int J Cancer] 2024 May 15; Vol. 154 (10), pp. 1719-1730. Date of Electronic Publication: 2024 Jan 23.

Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communication

Autor: G. Westman, S. Borgström, H. Modig, I. Nilsson

Publikováno v: Journal of steroid biochemistry. 36(3)

Twelve postmenopausal women with inoperable or metastatic breast cancer were given toremifene at a daily dose of 60 mg. The patients had no prior endocrine or cytotoxic therapy and further inclusion criteria were bidimensionally measurable disease, p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea4131129578d3195a89c0cef6f6512
https://pubmed.ncbi.nlm.nih.gov/2142242